— Know what they know.
Not Investment Advice

CV NASDAQ

CapsoVision, Inc.
1W: +1.1% 1M: -2.5% 3M: +1.8% YTD: -34.1% 1Y: +37.8%
$6.75
-0.14 (-2.03%)
 
Weekly Expected Move ±6.0%
$6 $7 $7 $7 $8
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 66 · $359.2M mcap · 4M float · 4.16% daily turnover · Short 71% of daily vol
Credit Risk of going bust: lower than 65% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), CapsoVision, Inc. would be worth roughly what it owes.
Total debt $687K against a stock market value of $359.2M.
Distance to default 6.83 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $344K (short-term plus half of long-term), stock volatility 95.8%; Altman Z 23.26. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Bullish 75
Insider+$21.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$359.2M
52W Range4.5-15.37
Volume111,617
Avg Volume174,056
Beta-2.46
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOKang-Huai Wang
Employees99
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-07-02
18805 Cox Avenue
Saratoga, CA 95070
US
14086241488
About CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Recent Insider Trades

NameTypeSharesPriceDate
HARARI ELIYAHOU ET A P-Purchase 878,735 $5.69 2026-09-18
HARARI ELIYAHOU ET A P-Purchase 878,734 $5.69 2026-09-18
Shen Ching Hang P-Purchase 878,734 $5.69 2026-09-15
Shen Ching Hang P-Purchase 878,734 $5.69 2026-09-15
HARARI ELIYAHOU ET A P-Purchase 61,068 $6.73 2026-07-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms